Janney Montgomery Scott Starts Alnylam Pharmaceuticals (ALNY) at Neutral
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Janney Montgomery Scott initiated coverage on Alnylam Pharmaceuticals (NASDAQ: ALNY) with a Neutral rating and a price target of $74.
Shares of Alnylam Pharmaceuticals closed at $78.09 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Janney Montgomery Scott Starts Ametek Inc. (AME) at Buy
- UPDATE: Seaport Global Securities Starts Union Pacific (UNP) at Buy
- JMP Securities Starts MedEquities Realty Trust (MRT) at Market Outperform
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesJanney Montgomery Scott
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!